About Asymchem
Asymchem is a publicly listed company based in Morrisville (United States) founded in 1995. APIs and peptides are developed and manufactured by Asymchem. The company has 48 employees. Asymchem has completed 1 acquisition, including Snapdragon Chemistry. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Continuus Pharma and Pharmaceutics International; 1 of its 2 listed competitors has raised funding.
Company details
Asymchem is focussed on the process development and commercial manufacturing of APIs and peptides. Their facilities have been approved by USFDA and Australian TGA for API manufacturing and CFDA for drug product manufacturing. They claim that they have an added advantage of in-house raw materials manufacturing, through which they can control availability and lead-times. Asymchem offers services such as process optimization, pilot manufacturing and DMF filing of peptides and peptide containing drugs. They offer FDF services such as Blending, Encapsulation, Granulation wet granulation, roller compaction and fluid bed granulation, Fluid bed drying, Particle coating, Tablet compression, Tablet film coating immediate and modified release film coat for oral solid dosage forms. They also offer pre-formulation, formulation development, analytical services and stability studies. The companys capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, Highly Potent APIs, cryogenic, catalytic hydrogenation, etc.,
- Headquarters Morrisville, United States
- Employees 48
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website asymchem.com
- Social LinkedIn
- Latest Funding Round$330.56M (USD), Post-IPO
Feb 2020
- Investors
- Employee Count48
- Investments & Acquisitions
Funding Insights of Asymchem
- Total Rounds 1
- Last Round Post-IPO — $330.56M
- First Round $330.56M
(Feb 2020)
- Investors Count 1
All 1 funding rounds of Asymchem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $330.56M | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Asymchem
Asymchem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hillhouse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed with long-term focus. | hillhouseinvestment.com | New York, United States |
Investor details for Asymchem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Asymchem
11 people are tracked at Asymchem (7 in leadership, 4 in team); the tracked headcount is 48.
| Name | Role | Group |
|---|---|---|
Hao Hong | CEO & Chairman | Leadership |
Rui Yang | Chief Operating Officer | Leadership |
Da Zhang | Chief Financial Officer | Leadership |
Xiangke Xu | VP, Finance | Leadership |
Mark McLaws | VP, CMC & Development | Leadership |
James Gage | Chief Science Officer | Leadership |
Yan Zhou | VP, Quality Management | Leadership |
Elut Hsu | SVP, Business Development | Team |
Yingwei Jiang | SVP, Human Resources | Team |
Chaoyong Chen | SVP, Resource & Development | Team |
Yi Hsiao | SVP, Process Development & Application | Team |
Complete people profiles for Asymchem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asymchem
Asymchem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Snapdragon Chemistry.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drug discovery and development service provider | snapdragonchemistry.com | Cambridge, United States | 2014 | Feb 2022 | $57.94M |
Complete acquisition details for Asymchem
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Asymchem
4 dated milestones of Asymchem across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Asymchem is founded.
- Funding First funding round of $330.6M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Snapdragon Chemistry.
Competitors of Asymchem
Asymchem has 2 listed competitors in our database, 1 of them funded. They include Continuus Pharma and Pharmaceutics International.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Asymchem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Asymchem
The website of Asymchem (asymchem.com) receives about 9.9K visits a month.
- Monthly visits9.9K
▲ 34.3% vs previous month
Websites whose visitors overlap most with Asymchem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scytek.com | 100% | 5.1K | #3,738,821 | View details | |
npscorp.com | npscorp.com | 59% | – | ||
| phoenixpeptide.com | 34% | 102.4K | #300,152 | View details | |
| bachem.com | 32% | 167.9K | #280,794 | View details | |
agelesshumans.com | agelesshumans.com | 31% | #2,635,274 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Asymchem
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Asymchem (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Asymchem
Complete news archive for Asymchem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asymchem
Asymchem was founded in 1995 and raised its 1st funding round 25 years after it was founded.
Asymchem is headquartered in Morrisville, United States.
Asymchem has 48 employees.
Asymchem is focussed on the process development and commercial manufacturing of APIs and peptides. Their facilities have been approved by USFDA and Australian TGA for API manufacturing and CFDA for drug product manufacturing. They claim that they have an added advantage of in-house raw materials manufacturing, through which they can control availability and lead-times. Asymchem offers services such as process optimization, pilot manufacturing and DMF filing of peptides and peptide containing drugs. They offer FDF services such as Blending, Encapsulation, Granulation wet granulation, roller compaction and fluid bed granulation, Fluid bed drying, Particle coating, Tablet compression, Tablet film coating immediate and modified release film coat for oral solid dosage forms. They also offer pre-formulation, formulation development, analytical services and stability studies. The companys capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, Highly Potent APIs, cryogenic, catalytic hydrogenation, etc.,.
Asymchem's top competitors include Pharmaceutics International and Continuus Pharma.
Asymchem has made 1 acquisition, including Snapdragon Chemistry.
Asymchem has 1 investor. Key investors include Hillhouse.